These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6813486)

  • 1. The problems of studying disease-remittive agents in RA.
    Huskisson EC
    J Rheumatol Suppl; 1982; 8():201-6. PubMed ID: 6813486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Auranofin.
    Davis P
    Clin Rheum Dis; 1984 Aug; 10(2):369-83. PubMed ID: 6239742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
    Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K
    J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
    Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR
    Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Other penicillamine-like drugs.
    Huskisson EC
    J Rheumatol Suppl; 1981; 7():180-1. PubMed ID: 6785437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study.
    Schattenkirchner M; Kaik B; Muller-Fassbender H; Rau R; Zeidler H
    J Rheumatol Suppl; 1982; 8():184-9. PubMed ID: 6813483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Auranofin versus penicillamine in rheumatoid arthritis. One-year results from a prospective clinical investigation.
    Manthorpe R; Hørbov S; Sylvest J; Vinterberg H
    Scand J Rheumatol; 1986; 15(1):13-22. PubMed ID: 3083505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cells with immunoregulatory function: the human macrophages and the effects of remittive drugs.
    Harth M; Keown PA; Orange J
    J Rheumatol Suppl; 1983 Dec; 11():76-80. PubMed ID: 6230447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of auranofin compared to placebo in rheumatoid arthritis.
    Katz WA; Alexander S; Bland JH; Blechman W; Bluhm GB; Bonebrake RA; Falbo A; Greenwald RA; Hartman S; Hobbs T; Indenbaum S; Lergier JE; Lanier BG; Lightfoot RW; Phelps P; Sheon RP; Torretti D; Wenger ME; Wilske K
    J Rheumatol Suppl; 1982; 8():173-8. PubMed ID: 6813481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Auranofin or D-penicillamine in the treatment of rheumatoid arthritis.
    Hochberg MC
    Ann Intern Med; 1986 Oct; 105(4):528-35. PubMed ID: 3092712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An analysis of worldwide safety experience with auranofin.
    Heuer MA; Pietrusko RG; Morris RW; Scheffler BJ
    J Rheumatol; 1985 Aug; 12(4):695-9. PubMed ID: 3932651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Auranofin treatment for adult rheumatoid arthritis. Comparison of 2 mg and 6 mg daily dose.
    Bernhard GC
    J Rheumatol Suppl; 1982; 8():149-53. PubMed ID: 6813477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Auranofin: 1 mg or 9 mg? The search for the appropriate dose.
    Calin A; Saunders D; Bennett R; Jacox R; Kaplan D; O'Brien W; Paulus HE; Roth S; Weiss T
    J Rheumatol Suppl; 1982; 8():146-8. PubMed ID: 6813476
    [No Abstract]   [Full Text] [Related]  

  • 14. Loose stools during auranofin treatment: clinical study and some pathogenetic possibilities.
    van Riel PL; Gribnau FW; van de Putte LB; Yap SH
    J Rheumatol; 1983 Apr; 10(2):222-6. PubMed ID: 6408256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gold therapy in rheumatoid arthritis. Interim report of the Canadian multicenter prospective trial comparing sodium aurothiomalate and auranofin.
    Menard HA; Beaudet F; Davis P; Harth M; Percy JS; Russell AS; Thompson JM
    J Rheumatol Suppl; 1982; 8():179-83. PubMed ID: 6813482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auranofin in rheumatoid arthritis.
    Champion GD; Bieri D; Browne CD; Day RO; Graham GG; Haavisto TM; Sambrook PN; Vallance JB
    J Rheumatol Suppl; 1982; 8():137-45. PubMed ID: 6813475
    [No Abstract]   [Full Text] [Related]  

  • 17. Rheumatoid factor by laser nephelometry and Waaler-Rose assay: prognostic value in patients with recent-onset rheumatoid arthritis.
    Nikolaisen C; Rekvig OP; Nossent HC
    Scand J Rheumatol; 2005; 34(4):269-76. PubMed ID: 16195159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral chrysotherapy in rheumatoid arthritis: minimum effective dose.
    Finkelstein AE; Roisman FR; Batista V; de Nudelman FG; de Titto EH; Mizraji M; Walz DT
    J Rheumatol; 1980; 7(2):160-8. PubMed ID: 6768887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The side effects of penicillamine therapy in rheumatoid arthritis.
    Huskisson EC
    J Rheumatol Suppl; 1981; 7():146-8. PubMed ID: 6939876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Possible mechanism of action of drugs in the basic therapy of rheumatoid arthritis: effect on platelet aggregation].
    Fioravanti A; Lolatte V; Giordano N; Frati E; Castagna ML; Morozzi G; Lalumera M; Marcolongo R
    Boll Soc Ital Biol Sper; 1984 May; 60(5):1051-6. PubMed ID: 6432005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.